VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
+$925K
2
LLY icon
Eli Lilly
LLY
+$843K
3
MRNA icon
Moderna
MRNA
+$824K
4
PFE icon
Pfizer
PFE
+$803K
5
MRK icon
Merck
MRK
+$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
+$1.5M
3
MOS icon
The Mosaic Company
MOS
+$716K
4
STR
Sitio Royalties
STR
+$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CLDX icon
351
Celldex Therapeutics
CLDX
$1.61B
$130K 0.05%
4,816
+685
+17% +$18.5K
SGMO icon
352
Sangamo Therapeutics
SGMO
$157M
$130K 0.05%
31,424
+10,441
+50% +$43.2K
IBRX icon
353
ImmunityBio
IBRX
$2.43B
$129K 0.05%
34,799
+7,456
+27% +$27.6K
IMAB
354
I-MAB
IMAB
$376M
$129K 0.05%
11,446
+8,310
+265% +$93.7K
IVVD icon
355
Invivyd
IVVD
$255M
$129K 0.05%
39,281
+17,926
+84% +$58.9K
RGNX icon
356
Regenxbio
RGNX
$500M
$129K 0.05%
5,209
+379
+8% +$9.39K
VXRT
357
DELISTED
Vaxart
VXRT
$129K 0.05%
36,904
+11,521
+45% +$40.3K
PCVX icon
358
Vaxcyte
PCVX
$4.25B
$128K 0.05%
+5,865
New +$128K
RNA icon
359
Avidity Biosciences
RNA
$6B
$128K 0.05%
8,781
+2,495
+40% +$36.4K
EQRX
360
DELISTED
EQRx, Inc. Common Stock
EQRX
$128K 0.05%
+27,289
New +$128K
AFMD
361
DELISTED
Affimed
AFMD
$127K 0.05%
4,568
+1,681
+58% +$46.7K
ALXO icon
362
ALX Oncology
ALXO
$58.4M
$127K 0.05%
15,641
+9,176
+142% +$74.5K
ARCT icon
363
Arcturus Therapeutics
ARCT
$487M
$127K 0.05%
8,039
+3,507
+77% +$55.4K
RAPT icon
364
RAPT Therapeutics
RAPT
$225M
$127K 0.05%
871
+236
+37% +$34.4K
RCUS icon
365
Arcus Biosciences
RCUS
$1.2B
$127K 0.05%
5,029
+1,075
+27% +$27.1K
SNDX icon
366
Syndax Pharmaceuticals
SNDX
$1.37B
$127K 0.05%
6,584
-2,139
-25% -$41.3K
GERN icon
367
Geron
GERN
$868M
$126K 0.05%
81,016
-40,127
-33% -$62.4K
SWTX
368
DELISTED
SpringWorks Therapeutics
SWTX
$126K 0.05%
5,111
+2,823
+123% +$69.6K
ABCL icon
369
AbCellera Biologics
ABCL
$1.27B
$125K 0.05%
11,784
– –
DVAX icon
370
Dynavax Technologies
DVAX
$1.16B
$125K 0.05%
9,904
-1,688
-15% -$21.3K
IDYA icon
371
IDEAYA Biosciences
IDYA
$2.17B
$125K 0.05%
9,088
+1,896
+26% +$26.1K
INO icon
372
Inovio Pharmaceuticals
INO
$146M
$125K 0.05%
6,001
+3,814
+174% +$79.4K
PRLD icon
373
Prelude Therapeutics
PRLD
$67.4M
$125K 0.05%
24,005
+10,957
+84% +$57.1K
RLAY icon
374
Relay Therapeutics
RLAY
$702M
$125K 0.05%
7,476
+1,918
+35% +$32.1K
REPL icon
375
Replimune Group
REPL
$454M
$124K 0.05%
7,108
+1,461
+26% +$25.5K
13 14
15
16 17